Insider Transactions last 24 months for Trevi Therapeutics, Inc.  -  NSDQ: TRVI

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Sciascia ThomasChief Scientific Officer03/25/2025DSDirectCOM2,631$6.60$17,364.60221,373
Sciascia ThomasChief Scientific Officer03/25/2025AMDirectCOM2,631$1.43$3,762.33224,004
Good Jennifer LPresident & CEO03/21/2025DSDirectCOM5,263$6.58$34,624.75213,313
Good Jennifer LPresident & CEO03/21/2025AMDirectCOM5,263$1.43$7,526.09218,576
Simon FarrellChief Commercial Officer03/10/2025DSDirectCOM4,350$7.15$31,101.6376,900
Simon FarrellChief Commercial Officer03/10/2025DSDirectCOM76,963$6.73$517,776.2881,250
Simon FarrellChief Commercial Officer03/10/2025AMDirectCOM31,250$0.51$15,968.75158,213
Simon FarrellChief Commercial Officer03/10/2025AMDirectCOM63,813$3.91$249,508.83126,963
Simon FarrellChief Commercial Officer03/10/2025AMDirectCOM17,500$3.21$56,175.0063,150
Delfini LisaChief Financial Officer01/08/2025AMDirectCOM5,000$0.51$2,555.0064,660
Delfini LisaChief Financial Officer01/07/2025AMDirectCOM1,000$0.51$511.0059,660
Galletta ChristopherSee Remarks12/13/2024AMDirectCOM15,000$0.51$7,665.0019,935
Good Jennifer LPresident & CEO09/09/2024DSDirectCOM1,840$3.04$5,586.61213,313
Good Jennifer LPresident & CEO09/09/2024AMDirectCOM1,840$1.43$2,631.20215,153
Good Jennifer LPresident & CEO09/06/2024DSDirectCOM4,219$3.03$12,784.41213,313
Good Jennifer LPresident & CEO09/06/2024AMDirectCOM4,219$1.43$6,033.17217,532
Good Jennifer LPresident & CEO09/05/2024DSDirectCOM40,277$3.11$125,309.80213,313
Good Jennifer LPresident & CEO09/05/2024AMDirectCOM40,277$1.43$57,596.11253,590
Good Jennifer LPresident & CEO09/04/2024DSDirectCOM10,981$3.02$33,205.45213,313
Good Jennifer LPresident & CEO09/04/2024AMDirectCOM10,981$1.43$15,702.83224,294
Good Jennifer LPresident & CEO09/03/2024DSDirectCOM3,863$3.02$11,677.46213,313
Good Jennifer LPresident & CEO09/03/2024AMDirectCOM3,863$1.43$5,524.09217,176
Meeker David PDirector08/27/2024DSDirectCOM4,555$2.93$13,352.53352,489
Meeker David PDirector08/27/2024AMDirectCOM4,555$1.43$6,513.65357,044
Sciascia ThomasChief Scientific Officer08/19/2024DSDirectCOM16,496$2.96$48,882.60220,315
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel